TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMA

ImageneBio, Inc.

Healthcare · Biotechnology

4.70$ -3.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +315.8% +95.9% +47.2% -30.5% +11.5% -26.3% +8.1%
– +326.5% +94.8% +42.5% -32.3% +11.7% -28.8% +10.3%
– +352.1% +98.0% +42.9% -74.2% +100.1% -67.1% -11.2%
– +352.1% +98.0% +42.9% -32.4% +11.8% -29.1% -39.1%
– – – – – – – –
– +121.7% +82.8% -85.2% -36.8% -11.7% -30.3% +27.4%
– +535.4% +16.6% -4.0% -20.9% -33.9% -24.1% +4.2%
– – – +895.2% +3.0% +86.6% +6.4% -40.2%
– -58.8% +127.0% +12.3% -12.2% -1.3% -56.6% +60.4%
– – – – -29.3% +15.5% -25.8% +5.7%
– – – – – – – –
– +0.0% +0.0% +0.3% +0.6% +15.3% -65.7% +354.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?